Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid omega-hydroxylation and 11,12-epoxidation by CYP4A2 protein

Archives of Biochemistry and Biophysics
M H WangM L Schwartzman

Abstract

20-Hydroxy-5,8,11,14-eicosatetraenoic acid (20-HETE), the omega-hydroxylation product of arachidonic acid, is the major metabolite produced in the kidney. It has potent biological effects on renal tubular and vascular functions and on the long-term control of arterial pressure. The synthesis of 20-HETE is catalyzed by enzymes of the CYP4A family, among which CYP4A2 is the most abundant isozyme expressed in the kidneys of rats. We have cloned and sequenced the CYP4A2 cDNA from the kidney of Lewis-Wistar rats and directed its expression using baculovirus and Sf9 insect cells. A high level of expression of CYP4A2 was evident by Northern, Western, and spectral analyses revealing a P450 content of 0.3 nmol/mg microsomal protein. To study CYP4A2-catalyzed arachidonic acid omega-hydroxylation, Sf9 cells were coinfected with CYP4A2 and NADPH cytochrome P450 oxidoreductase (OR) recombinant viruses. CYP4A2/OR membranes metabolized lauric acid at a high rate (7 and 5.5 nmol/min/nmol P450 in the presence and absence of b5, respectively). However, arachidonic acid omega-hydroxylase activity was barely detectable. When purified OR was added to the membranes expressing CYP4A2 protein, a concentration-dependent production of 20-HETE was observ...Continue Reading

Citations

Nov 9, 2000·Clinical and Experimental Pharmacology & Physiology·R J RomanM Alonso-Galicia
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Deanna L Kroetz, Fengyun Xu
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·M M MuthalifK U Malik
Aug 1, 2006·Drug Metabolism Reviews·Brian R Baer, Allan E Rettie
Feb 27, 2016·Molecular Pharmaceutics·Ahmed A El-Sherbeni, Ayman O S El-Kadi
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Yoshitaka YamaguchiTakashi Matsubara
Jul 8, 2000·Circulation Research·D GebremedhinD R Harder
Mar 18, 2006·Circulation Research·Ji-Shi WangMichal Laniado-Schwartzman
Sep 25, 2004·Circulation Research·Kasem NithipatikomGarrett J Gross
Feb 28, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Xueying ZhaoJohn D Imig
May 6, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Richard A GrahamEdward L Lecluyse
Jun 30, 2001·Canadian Journal of Physiology and Pharmacology·J J McGuireC R Triggle
Jul 23, 2004·The Journal of Pharmacology and Experimental Therapeutics·Ji-Shi WangMichal Laniado-Schwartzman
Feb 24, 2001·Current Opinion in Nephrology and Hypertension·K G Maier, R J Roman
Nov 28, 2012·British Journal of Pharmacology·Hassan N AlthurwiAyman O S El-Kadi
Mar 5, 1998·The American Journal of Physiology·O ItoR J Roman
Sep 14, 1999·The American Journal of Physiology·J C McGiff, J Quilley
Jun 13, 2002·American Journal of Physiology. Renal Physiology·Jackleen S MarjiMichal Laniado-Schwartzman
Dec 30, 2014·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Fan FanRichard J Roman
Feb 10, 1999·The American Journal of Physiology·M H WangM Laniado-Schwartzman
Nov 30, 2000·American Journal of Physiology. Renal Physiology·J D Imig
Jun 11, 1999·The American Journal of Physiology·O Ito, R J Roman
Feb 15, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·O ItoR J Roman
Jun 19, 2002·Journal of Applied Physiology·Daling ZhuElizabeth R Jacobs
Apr 10, 2003·American Journal of Physiology. Renal Physiology·Mong-Heng WangMichal Laniado-Schwartzman
Aug 30, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Beshay N M ZordokyAyman O S El-Kadi
Dec 13, 2005·The Journal of Pharmacology and Experimental Therapeutics·Yiqiang ZhouMong-Heng Wang
Jun 11, 1999·The American Journal of Physiology·X NguyenM L Schwartzman
Jul 17, 2001·Biochemical and Biophysical Research Communications·J H Capdevila, J R Falck
Aug 30, 2000·Prostaglandins & Other Lipid Mediators·J H Capdevila, J R Falck
Nov 27, 1999·Molecular Aspects of Medicine·J A Hasler
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Jorge H Capdevila, John R Falck
May 17, 2003·Prostaglandins & Other Lipid Mediators·David Bishop-Bailey, Jessica Wray

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.